1. II. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy: Update 2000 
American Journal of Kidney Diseases 
Volume 37, Issue 1, Pages S65-S136 (January 2001)
DOI: /S (01)
Copyright © Terms and Conditions

2. Fig II
1. Solute removal and initiation of PD. Example of tracking solute clearance measurements for a single patient over a 12-month period. The point at which incremental PD was initiated is indicated by the arrow.
American Journal of Kidney Diseases  , S65-S136DOI: ( /S (01) )
Copyright © Terms and Conditions

3. Fig II
2. Dose of PD with respect to weekly creatinine clearance relative to weekly Kpr t/V. The dose of PD with respect to weekly creatinine clearance relative to weekly Kpr t/V varies widely depending on the definition of renal creatinine clearance.
American Journal of Kidney Diseases  , S65-S136DOI: ( /S (01) )
Copyright © Terms and Conditions

4. Fig II
3. Equivalent total dialysis doses for incremental replacement of Kpr t/Vurea . Assumptions are made that the Kr , Kp , and Kd are clinically equivalent clearance items. Another assumption for this particular model is that an equal nPCR, the CAPD steady-state BUN equals the average prehemodialysis BUN. Thus, the intermittent hemodialysis dose can be related to the continuous dialysis (CAPD) by the various curves. N = (2) 1, (○) 2, or (■) 3 refers to once, twice, or thrice weekly hemodialysis treatments, respectively. The vertical axis is the equilibrated (double pool) delivered and normalized hemodialysis dose. Equilibrated Kt/V is about 0.21 lower than single pool and is necessary to use here because the CAPD steady-state is equilibrated.
American Journal of Kidney Diseases  , S65-S136DOI: ( /S (01) )
Copyright © Terms and Conditions